Updated Jul 16, 2026
Porter Derrell has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $75K.

Porter Derrell is a person named in SEC filings related to Passage Bio, Inc. as of May 21, 2026. Public biographical information about Derrell is limited beyond his appearance as an insider or employee in the company's SEC disclosures. No widely published profile or detailed professional history was found in standard sources available to this system.
| Role | Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | ABOS | Acumen Pharmaceuticals, Inc. | S — Open-market sale | 13.0K | $2.33 | $30K |
| 2026-06-17 | ABOS | Acumen Pharmaceuticals, Inc. | M — Option exercise | 13.0K | $1.07 | $14K |
| 2026-06-17 | ABOS | Acumen Pharmaceuticals, Inc. | S — Open-market sale | 12.8K | $2.33 | $30K |
| 2026-06-17 | ABOS | Acumen Pharmaceuticals, Inc. | S — Open-market sale | 6.5K | $2.35 | $15K |
| 2026-06-17 | ABOS | Acumen Pharmaceuticals, Inc. | M — Option exercise | 6.5K | $1.07 | $7K |
| 2026-06-05 | ABOS | Acumen Pharmaceuticals, Inc. | A — Grant or award | 35.5K | $0.00 |
Porter Derrell is a person named in SEC filings related to Passage Bio, Inc. as of May 21, 2026. Public biographical information about Derrell is limited beyond his appearance as an insider or employee in the company's SEC disclosures. No widely published profile or detailed professional history was found in standard sources available to this system.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($75K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Porter Derrell profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.